Preliminary applications will only be accepted until February 15, 2017. If you plan to submit an EEMS application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application. The deadline for full application submission is April 3, 2017.

Information is available regarding the PLCO trial and PLCO biospecimens.

Please visit the EEMS Application for Biospecimens page to preview instructions about the process, review the EEMS Policies and Procedures, and begin an EEMS Preliminary Application for Biospecimens.

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

Preliminary applications will only be accepted from November 15, 2016 through Jan. 16, 2017. If you plan to submit a grant application this cycle, an approved preliminary grant application is required. Please see PAR Application for Biospecimens and Funding for more information. Once your preliminary grant application has been approved, you will receive a confirmation letter to accompany your grant application.

Information is available regarding the PLCO trial and PLCO biospecimens

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

Preliminary applications for PLCO EEMS Round 23 will only be accepted from January 2 through February 15, 2017. If you plan to submit an EEMS Application for Biospecimens this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application. The deadline for full application submission is April 3, 2017.

Information is available regarding the PLCO trial and PLCO biospecimens

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

HSQ documentation was updated to include the forms for the intervention arm participants. Also, the description of HSQ questions was updated to emphasize that intervention arm participants were instructed only to report screening exams received after their last PLCO trial exam of that type. See: https://cdas.cancer.gov/learn/plco/follow-up-qx/

PLCO EEMS Round 22 is closed to applications. The deadline for PLCO EEMS full applications was September 1, 2016. Please check CDAS for updates on the next round of PLCO EEMS proposal review. If you have any questions about project feasibility and specimen availability for future EEMS rounds, please contact CDAS staff at cdas-eems@imsweb.com.